Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1098 of 5804
-
New eye drops aim to heal damaged corneas
Symptom relief Recruiting nowObjective: To evaluate the safety of Lacripep 4 μM Ophthalmic Solution and its effect on the ocular surface, visual function, corneal sensitivity, and quality of life of subjects with Stage 1 NK.
Phase: PHASE2 • Sponsor: TearSolutions, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Sham surgery showdown: is the knife worth it for sciatica?
Symptom relief Recruiting nowThe FINDISC trial studies whether common back operation, microdiscectomy, is effective and safe for treating sciatica caused by a lumbar disc herniation. The study includes people whose leg pain has not improved after at least six weeks of non-surgical treatment. The FINDISC tri…
Phase: NA • Sponsor: Helsinki University Central Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Online lifestyle program aims to cut breast cancer risk in High-Risk women
Prevention Recruiting nowBreast cancer remains the most common cancer among women and a major cause of death despite advances in screening and treatment. Current screening programs are not personalized and are experiencing declining participation. A promising strategy for breast cancer control would be t…
Phase: NA • Sponsor: UNICANCER • Aim: Prevention
Last updated Jul 25, 2026 00:00 UTC
-
New drug SB-4826 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThe goal of this clinical trial is to learn what dose of the drug SB-4826 can be given safely in patients with solid tumors and non-Hodgkin lymphomas. This drug will be used alone in patients with solid tumors, and will be used alone or in combination with rituximab in patients w…
Phase: PHASE1, PHASE2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Simple skin test may spot Parkinson's risk years early
Knowledge-focused Recruiting nowBackground and Rationale Essential tremor (ET) affects over 6 million Americans and approximately 5% of adults over age 60. Patients with ET have a 10-20 times higher risk of developing Parkinson's disease (PD) compared to age-matched populations, with approximately 1% converting…
Sponsor: CND Life Sciences • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
AR goggles guide surgeons to leftover cancer cells in head and neck surgery
Knowledge-focused Recruiting nowHead and neck cancers have one of the highest recurrence rates among solid malignancies, and recurrence is strongly correlated with overall survival. Reducing recurrence rates depends, in part, on the surgeon's ability to accurately re-resect areas of positive or close margins du…
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Malaria vaccine booster trial aims to keep school kids protected
⭐️ VACCINE ⭐️ Recruiting nowThis trial is a double-blind, randomised, trial recruiting participants from the R21 phase IIb trial (VAC 076) which took place between May 2019 and July 2023 in Nanoro, Burkina Faso. Participants (n=30-40) who have previously received four doses of the 5µg R21/50µg Matrix-M mal…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 09:08 UTC
-
New immune combo takes on tough pancreatic cancer
Disease control Recruiting nowThis is an open-label, single-arm clinical study designed to evaluate the safety and preliminary efficacy of Claudin18.2 Targeted Activated DC combined with CAR-T therapy in patients with Advanced Pancreatic Cancer. This combination therapy activates dendritic cells (DCs) to pre…
Phase: EARLY_PHASE1 • Sponsor: Hainan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Choice of injectable opioid treatment may help former inmates stay on track
Disease control Recruiting nowThe goal of this pilot trial is to compare two branded extended-release buprenorphine (XR-B) formulations (Sublocade vs. Brixadi) to explore how they improve treatment retention after release from prison among incarcerated individuals with opioid use disorder (OUD) who are transi…
Phase: PHASE4 • Sponsor: Lifespan • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New Clot-Sucking device could limit heart attack damage
Disease control Recruiting nowThe aim of this study is to evaluate the impact of sustained thrombectomy with INDIGO ASPIRATION SYSTEM using CAT RX versus no thrombectomy during primary percutaneous coronary intervention (PPCI) on microvascular obstruction and infarct size, as measured by cardiovascular magnet…
Phase: NA • Sponsor: Ceric Sàrl • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for rheumatoid arthritis sufferers: experimental drug ELV001 enters phase 2 trial
Disease control Recruiting nowThis is a Phase 2 randomized, double-blind, placebo-controlled study with a total duration of 32 weeks from Screening to End-of-Study (EOS) Visit. Approximately 180 participants are planned to be enrolled. The number of participants can be extended to maximally 220 to account for…
Phase: PHASE2 • Sponsor: Elevara Medicines Limited • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Arm rehab showdown: which therapy boosts hand function in kids with CP?
Disease control Recruiting nowChildren with spastic diplegic cerebral palsy often experience upper extremity impairments, including reduced coordination, muscle control, and functional hand use, which limit independence in daily activities. Proprioceptive Neuromuscular Facilitation (PNF) and Task-Oriented Tra…
Phase: NA • Sponsor: Ibadat International University, Islamabad • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for advanced cancer: experimental drug CR-001 enters human trials
Disease control Recruiting nowThe purpose of this study is to determine the safety and tolerability of monotherapy CR-001 and identify the maximum tolerated dose (MTD), and/or optimal biologic dose and Recommended Phase 2 Dose(s) (RP2D) in participants with locally advanced or metastatic solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Crescent Biopharma, Inc. • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
New psoriasis pill shows promise in major trial
Disease control Recruiting nowAn open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis
Phase: PHASE3 • Sponsor: Vanda Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New sensor aims to cut hospital visits after heart valve fix
Disease control Recruiting nowTricuspid regurgitation (TR) is a severe and highly prevalent disease that leads to right-sided heart failure. The severity of TR is associated with increasing morbidity and mortality. While severe TR and right-sided heart failure have an impact on the quality of life and prognos…
Phase: NA • Sponsor: LMU Klinikum • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New hope for rare blood cancers: experimental drug ELA026 enters human testing
Disease control Recruiting nowThis is a Phase 1, two-part, multicenter study to evaluate ELA026 in participants ≥18 years old with relapsed/refractory TCM following any line of prior therapy who are eligible for investigational treatments.
Phase: PHASE1 • Sponsor: Electra Therapeutics Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug targets Hard-to-Treat colorectal cancer in early trial
Disease control Recruiting nowThis trial will evaluate the safety, tolerability, and preliminary efficacy of tegavivint as monotherapy (single) and in combination with standard therapies in patients with metastatic colorectal carcinoma (mCRC).
Phase: PHASE1, PHASE2 • Sponsor: HonorHealth Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Meat or fat? diet study aims to tame IBD and arthritis symptoms
Symptom relief Recruiting nowThis study is a randomized controlled clinical trial evaluating whether two therapeutic dietary approaches - a ketogenic diet and a carnivore (lion) diet - can improve quality of life, reduce symptoms, and influence measures of disease activity in adults with inflammatory bowel d…
Phase: NA • Sponsor: Fuller Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New sealant aims to stop brain fluid leaks during neurosurgery
Disease control Recruiting nowThis is a multicentre, prospective, open-label, single-arm, observational, post-market clinical follow-up registry study designed to observe the safety and performance of the Immiseal™ Dural Sealant System when used as an adjunct to standard methods of dural repair to provide wat…
Sponsor: Medprin Regenerative Medical Technologies Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New pancreatic cyst test could prevent cancer by guiding treatment
Diagnosis Recruiting nowThe purpose of this research is to learn if the PanCystPro assay can help doctors in making decisions about treatment and monitoring of pancreatic cysts. The PanCystPro test measures glucose, carcinoembryonic antigen (CEA), and gastricsin biomarkers on fluid obtained from a pancr…
Sponsor: Amplified Sciences Inc • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC